Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New matrix metalloproteinase inhibitors for respiratory disorders emerge from Pfizer research

April 1, 2005

InterMune works towards phase III program for pirfenidone in IPF

April 1, 2005

Phase II study evaluates MN-001 in asthma

April 1, 2005

VDM-11 produces antitussive effect in mice

March 31, 2005

New treatments for respiratory disorders described in patent literature

March 30, 2005

Phase II study of IC-485 in COPD fails to meet primary endpoint

March 30, 2005

Rosiglitazone protects against experimental acute lung injury

March 29, 2005

Leukolysin: a new target for asthma

March 29, 2005

Immunization studies reveal a novel human asthma vaccine

March 29, 2005

BioWa licenses anti-IL-5 receptor antibody from Kyowa Hakko Kogyo

March 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...